| Literature DB >> 21697013 |
Kaori Sakuishi1, Pushpa Jayaraman, Samuel M Behar, Ana C Anderson, Vijay K Kuchroo.
Abstract
T cell immunoglobulin-3 (Tim-3) has been identified as a marker of differentiated interferon-γ-producing CD4(+) T helper type 1 and CD8(+) T cytotoxic type 1 cells. The interaction of Tim-3 with its ligand, galectin-9 (Gal-9), induces cell death, and in vivo blockade of this interaction results in exacerbated autoimmunity and abrogation of tolerance in experimental models, establishing Tim-3 as a negative regulatory molecule. Recent studies have uncovered additional mechanisms by which Tim-3 negatively regulates T cell responses, such as promoting the development of CD8(+) T cell exhaustion and inducing expansion of myeloid-derived suppressor cells. In contrast to this inhibitory effect on T cells, Tim-3-Gal-9 interaction promotes macrophage clearance of intracellular pathogens. Here, we focus on the emerging role for Tim-3 in tumor and antimicrobial immunity.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21697013 PMCID: PMC3164311 DOI: 10.1016/j.it.2011.05.003
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 16.687